Introduction
Male breast cancer (MBC) is rare, occurring in ~1% of all breast cancers. While clinically characterized as being similar to postmenopausal ER+ BC, MBC has been much less characterized molecularly than female BC.
Publications
Multiplatform molecular profiling of male breast cancer (MBC) reveals significant differences in actionable targets from matched female breast carcinomas
– Caris Life Sciences
Download Publication